베타글루칸 시장 보고서 : 유형별, 공급원별, 업계별, 지역별(2025-2033년)

The global beta glucan market size reached USD 547.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 957.4 Million by 2033, exhibiting a growth rate (CAGR) of 6.4% during 2025-2033. The increasing applications of beta-glucan in functional foods and fortified beverages, along with the rising consumer awareness towards the benefits of adopting a healthy lifestyle, are primarily propelling the market.

Beta-glucan is a naturally occurring polysaccharide found in the cell walls of certain plants, fungi, and yeasts. This complex sugar is well-regarded for its various bioactive properties, making it a subject of keen interest in scientific research. One of its most notable characteristics is its ability to modulate the immune system, enhancing the body's defense mechanisms against pathogens. It is also recognized for its potential in lowering blood cholesterol levels, thereby contributing to cardiovascular health. Additionally, beta-glucan is soluble in water, which allows it to be easily integrated into foods, supplements, and pharmaceutical products. Its features such as high molecular weight and branching structure contribute to its efficacy in various applications ranging from healthcare to food and beverage industries. These unique characteristics have led to an increased demand for beta-glucan in the market, attesting to its versatile utility.

Global Beta Glucan Market

The rising demand for herbal medications represents one of the key factors driving the market growth. In line with this, the rising consumer demand for natural immunity boosters and the challenge of managing lifestyle diseases have accentuated the importance of beta-glucan in wellness regimes globally. This is acting as a major growth-inducing factor. Correspondingly, beta-glucan plays a crucial role in modulating the immune system and aiding in cardiovascular health, fulfilling a gap in consumer needs for natural, bioactive ingredients. The proliferation of online sales channels and efforts to standardize quality are further fueling market expansion. Additional elements, such as evolving health consciousness, a shift toward convenient yet nutritious supplements, and a sharp focus on sustainably sourced, non-GMO products are intensifying the growth of beta-glucan across multiple sectors worldwide.

Beta Glucan Market Trends/Drivers:

Health Awareness and Lifestyle Diseases

The rising global health awareness is a principal factor contributing to the escalating demand for beta-glucan. With an increase in lifestyle diseases such as cardiovascular ailments, diabetes, and obesity, consumers are actively seeking out natural solutions to manage these conditions. Beta-glucan is a bioactive compound well-documented for its immune-modulating and cholesterol-lowering capabilities. Its ability to naturally strengthen the immune system and improve cardiovascular health has garnered significant attention from health-conscious consumers. As public awareness campaigns and medical research continue to highlight the positive impact of beta-glucan on human health, this awareness acts as a catalyst, intensifying its market demand. The attractiveness of beta-glucan as a natural alternative to chemical-based medicines further consolidates its position in the market.

Technological Advancements in Extraction and Formulation

Another driving factor for the beta-glucan market is the advancement in technological processes for its extraction and formulation. Modern methodologies have enabled the production of beta-glucan with higher purity and bioavailability. These advancements make it easier for manufacturers to include beta-glucan in a diverse range of products such as dietary supplements, skincare products, and functional foods. As a result, not only does this increase the applicability of beta-glucan across various sectors, but it also adds value to the end products in which it is incorporated. With efficient extraction and formulation techniques, the industry can meet growing consumer demands more effectively, thereby propelling market growth.

Consumer Preference for Natural and Non-GMO Products

The market for beta-glucan is also influenced significantly by changing consumer preferences towards natural, organic, and non-GMO products. Today's consumer is well-informed and places considerable emphasis on the quality and sourcing of ingredients. Beta-glucan, typically extracted from natural sources like yeast, oats, and fungi, aligns well with this consumer outlook. The natural origin of beta-glucan makes it a favorable choice for those wary of synthetic or genetically modified options. Additionally, its natural label enhances its marketability, capturing the attention of a consumer base that is willing to invest in premium-quality natural products for their long-term health benefits.

Beta Glucan Market Segmentation:

Breakup by Type:

Soluble

Insoluble

Soluble represents the largest market segment

Soluble beta-glucan is often emphasized for its cholesterol-lowering and immune-boosting properties. It is more readily incorporated into beverages, functional foods, and dietary supplements designed for cardiovascular health and immune support. Segmenting the market based on the solubility of beta-glucan allows companies to specifically target consumer groups who are more health-conscious or dealing with particular health issues such as high cholesterol levels or weak immunity. The focused segmentation aids in tailoring product development, marketing strategies, and educational campaigns that speak directly to the consumer's needs and preferences. Understanding the particular requirements of the soluble beta-glucan segment enables companies to offer highly specialized solutions, thus giving them a competitive advantage and better aligning with consumer demand.

Breakup by Source:

Cereal

Mushroom

Yeasts

Seaweed

Yeasts represents the largest market segment

Beta-glucan extracted from yeast is renowned for its immune-modulating properties and is often used in dietary supplements, functional foods, and even in cosmetics for its skin-soothing benefits. Unlike its counterparts derived from oats or barley, yeast-derived beta-glucan is particularly sought after for its high purity and bioactivity. By focusing on the yeast-based beta-glucan market segment, companies can target a specialized consumer group interested in immune health, anti-aging skincare, or pharmaceutical applications. This segmentation allows for the development of targeted marketing strategies, including nuanced messaging that resonates with health-conscious consumers or those dealing with specific health concerns like lowered immunity or skin issues. Companies can also optimize their research and development expenditures to create products that meet the unique demands of this segment. Yeast-derived beta-glucan enables businesses to fine-tune their offerings, enhance customer satisfaction, and achieve a competitive edge in a burgeoning wellness market.

Breakup by Industry Vertical:

Animal Feed

Personal Care and Cosmetics

Pharmaceuticals

Others

In the animal feed sector, beta-glucan is increasingly recognized for its immunomodulatory and gut health-enhancing properties. The market can be segmented based on various livestock types like poultry, swine, and ruminants. For example, poultry feed enriched with beta-glucan could be marketed for its ability to boost resistance against common avian diseases. This specialized focus allows manufacturers to tailor their products and research to meet the nutritional requirements and health challenges specific to each livestock type. By doing so, they can differentiate themselves in a competitive market where health-promoting additives are a growing trend. Regulatory considerations, particularly regarding safety and efficacy, also play a significant role in this segment.

In the personal care and cosmetics sector, beta-glucan derived primarily from yeast or oats is a valued ingredient for its skin-soothing and anti-aging properties. The industry can be segmented based on skincare needs such as hydration, anti-aging, and sensitivity. Companies may develop targeted formulations for specific skin types or conditions, like eczema or prematurely aging skin. Understanding this segmentation enables businesses to create specialized products, engage in focused marketing campaigns, and even set premium pricing for highly specialized solutions. Regulatory compliance around ingredient safety is crucial here, especially if claims about skin benefits are being made.

In pharmaceuticals, beta-glucan is researched and utilized for its potential in immunotherapy and as an adjunct in treatments for conditions like cancer and infections. The market could be segmented based on therapeutic areas such as oncology, infectious diseases, and cardiovascular health. For instance, beta-glucan may be integrated into cancer treatment regimens to enhance the immune response. Recognizing the distinct requirements and regulatory landscapes of these segments is essential for pharmaceutical companies. They can tailor their research and development efforts, engage in clinical trials specific to each segment's needs, and navigate complex regulatory pathways to bring effective treatments to market.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Europe exhibits a clear dominance, accounting for the largest Beta glucan market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe accounted for the largest market share.

In the European market, beta-glucan has garnered significant attention for its health benefits, particularly in industries like food and beverages, pharmaceuticals, and cosmetics. Consumer awareness of health and wellness is generally high in Europe, making it a fertile market for beta-glucan products that tout benefits like immune support or cholesterol reduction. Moreover, the presence of a robust regulatory framework, such as EFSA (European Food Safety Authority), lends credibility to approved health claims, thus potentially driving market demand. Companies operating in this region would do well to tailor their marketing strategies to align with local consumer preferences and regulatory guidelines. This focus enables businesses to optimize their product offerings and effectively meet the demands of a health-conscious consumer base, thereby positioning themselves competitively.

Competitive Landscape:

The top key players in the beta-glucan market are engaging in extensive research and development (R&D) to enhance product efficacy and explore new applications across various industries such as food and beverages, pharmaceuticals, and cosmetics. Many are investing in clinical trials to substantiate the health benefits of beta-glucan, thereby gaining a competitive advantage and regulatory approvals for health claims. Collaboration and strategic partnerships are also common, as companies seek to extend their global footprint and penetrate emerging markets. These leaders are also focusing on sustainability, exploring innovative ways to source beta-glucan responsibly. Moreover, they are adopting advanced manufacturing techniques to improve yield and reduce costs, aiming for a competitive edge in an increasingly demanding market.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

American International Chemical LLC (LeBaronBrown Industries LLC)

Beta Bio Technology Sp Z O O

Ceapro Inc.

Garuda International Inc.

Kemin Industries Inc.

Kerry Group plc

Koninklijke DSM N.V.

Lallemand Inc.

Lantmannen

Super Beta Glucan Inc.

Tate & Lyle plc

Van Wankum Ingredients

Key Questions Answered in This Report

• 1. What was the size of the global beta glucan market in 2024?
• 2. What is the expected growth rate of the global beta glucan market during 2025-2033?
• 3. What are the key factors driving the global beta glucan market?
• 4. What has been the impact of COVID-19 on the global beta glucan market?
• 5. What is the breakup of the global beta glucan market based on the type?
• 6. What is the breakup of the global beta glucan market based on the source?
• 7. What are the key regions in the global beta glucan market?
• 8. Who are the key players/companies in the global beta glucan market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Beta Glucan Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Soluble
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Insoluble
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Source

• 7.1 Cereal
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Mushroom
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Yeasts
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Seaweed
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Industry Vertical

• 8.1 Animal Feed
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Personal Care and Cosmetics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Pharmaceuticals
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 American International Chemical LLC (LeBaronBrown Industries LLC)
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Beta Bio Technology Sp Z O O
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Ceapro Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Garuda International Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Kemin Industries Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Kerry Group plc
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 Koninklijke DSM N.V.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Lallemand Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Lantmannen
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Super Beta Glucan Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Tate & Lyle plc
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Van Wankum Ingredients
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio